Tempus announces Research Collaboration with Bristol Myers Squibb

Tempus, a leader in artificial intelligence and precision medicine, today announced a multi-year, strategic research collaboration with Bristol Myers Squibb (NYSE: BMY). The two companies will work together to identify new targets and validate them faster and with higher confidence using multimodal datasets, computational approaches, and patient-derived disease models in...

The post Tempus announces Research Collaboration with Bristol Myers Squibb first appeared on AI-TechPark.

artificial artificial intelligence collaboration companies computational confidence datasets disease faster identify intelligence leader machine learning medicine multimodal nyse patient precision precision medicine research targets them together work